Who is sponsoring NCT00817609?

NCT00817609 is sponsored by Fudan University.

What condition does NCT00817609 study?

NCT00817609 studies Stroke, Acute Ischemic Stroke.

What drugs are being tested in NCT00817609?

Interventions: Angongniuhuang Pill, placebo.

What is the status of NCT00817609?

NCT00817609 is currently UNKNOWN.

Last reviewed 2010-05-26 · How we verify

Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke

NCT00817609 Phase 2/Phase 3 UNKNOWN

This study will determine if Angongniuhuang Pill (Composed of Niuhuang, Yujin, Xijiao, Huangqin, Huanglian, Xionghuang, Zhizi, Zhusha, Bingpian, Shexiang, and Zhenzhu) will have a better effect in restoring consciousness for patients who have suffered from an acute ischemic stroke. The study is designed to look at both consciousness level and overall recovery and recovery of motor function, for example muscle strength and coordination.

Details

Lead sponsor	Fudan University
Phase	Phase 2/Phase 3
Status	UNKNOWN
Enrolment	60

Conditions

Stroke
Acute Ischemic Stroke

Interventions

Angongniuhuang Pill
placebo

Primary outcomes

Glasgow Coma Scale (GCS) within 90 days after stroke onset. — 90 days

Countries

China